EzySpot

Similar stories

Japan IVD Market By Diagnostics 2 years 17 weeks ago

According to Renub Research Japan In Vitro Diagnostics market is expected to surpass US$ 4.3 Billion by the end of year 2024. Renub Research report titled “Japan In Vitro Diagnostics (IVD) Market, By Diagnostics (Urine & Feces, Hematology, Clinical Chemistry, Self Monitoring of Blood Glucose (SMBG), Tumor Marker, Immunology, Infectious disease, Microbiology, Pathology and Genetic Testing) Companies (Roche Diagnostics, Sysmex Corporation, Abbott Laboratories & Others), Reimbursements, Porter's Model, Growth Drivers, Challenges, Opportunities” provides Japan In Vitro Diagnostics (IVD) Market.

Japan In Vitro Diagnostics (IVD) Market Outlook to 2024 2 years 15 weeks ago

Japan In Vitro Diagnostics Market, By Diagnostics (Urine & Feces, Hematology, Clinical Chemistry, Self Monitoring of Blood Glucose (SMBG), Tumor Marker, Immunology, Infectious disease, Microbiology, Pathology and Genetic Testing) Companies (Roche Diagnostics, Biomerieux, Abbott Laboratories & Danaher Corporation), Reimbursements, Porter's Model, Growth Drivers, Challenges, Opportunities

In Japan In vitro Diagnostic comes under medical device, which is consumable or disposable and used to collect numerous bio-samples under various medical conditions. Japan In vitro Diagnostics market is expected to surpass US$ 4.3 Billion by the end of year 2024.

China In Vitro Diagnostics Market Forecast 3 years 36 weeks ago

China is gradually becoming a competitive force and evolving into the world’s fastest growing market for In Vitro Diagnostics (IVD) products. By 2018 Chinese IVD market with Billion US$ is expected to be twice more than from its current market size in 2013. Immunoassay has the highest market share compared to all other segments of In Vitro Diagnostics. Clinical Chemistry is in the 2nd position, but its market share is declining year on year, however its market is growing year on year. Molecular Diagnostics holds the 3rd position and its market share is also rising year on year. Roche holds the highest market share in China In Vitro Diagnostics market.

China Molecular Diagnostic Test Volume 2 years 20 weeks ago

China Molecular Diagnostics Market is projected to reach US$ 1.8 Billion by the end of year 2024. Molecular diagnostics is a technique which is used for the molecular biological detection of any change in the structure or expression of patient’s genetic material. Renub Research report titled “China Molecular Diagnostics Market, Volume, by Application [Oncology Testing (Breast Cancer, Colorectal Cancer, Prostate Cancer), Infectious Disease Testing, and Genetic Disease Testing” provides a complete analysis of China Molecular Diagnostics Market.

China IVD market is predicted to grow with a double digit CAGR of 19.01% 3 years 17 weeks ago

As per Renub Research analysis China IVD market is predicted to grow with a double digit CAGR of 19.01% in future. China IVD market is forecasted to be three times from the present market. In vitro diagnostics are playing a gradually more vital role in the provision of healthcare. About 80% of the information that physicians use to make medical decisions is produced by diagnostics and clinical laboratories.China’s molecular diagnostics market is getting bigger because of the huge volume of PCR testing.

China In-vitro diagnostics market is expected to be triple its market size by the end of 2022 3 years 34 weeks ago

China In-vitro diagnostics market is expected to be triple its market size by the end of 2022 from its market size in 2016. China In-Vitro Diagnostics sector is expected to grow with a double digit CAGR of 19.01% in future. With such a huge growth rate China is poised to become the world’s largest In–vitro Diagnostics (IVD) Market in the next few years for both domestic and foreign IVD products. The In–Vitro Diagnostics (IVD) Market in China has been growing rapidly over the past few years and is expected to grow steadily in the coming future, with major growth potential in segments such as contagious disease testing, chronic disease testing and diagnosis in early stages of disease.

China – Forecast for Molecular Diagnostic Test Volume Share 3 years 32 weeks ago

China Molecular Diagnostics is a Billion dollar industry and its growing year on year rapidly. Molecular diagnostics holds immense potential in future of China Diagnostics Sector. It is predicted that China will perform over 300 Million molecular diagnostic tests during the forecasting period 2015 – 2019. Infectious disease and Oncology Testing both have almost equal share in China Molecular Diagnostics Sector. However in further sub–segmenting of molecular diagnostics market share perspective Virology Cancer Test holds the highest market share followed by Colorectal cancer and Breast Cancer Test.